In vitro antifungal susceptibility of Candida spp. oral isolates from HIV-positive patients and control individuals.
about
Quantitative and qualitative analyses of the cell death process in Candida albicans treated by antifungal agentsQuantitative and qualitative analysis of the antifungal activity of allicin alone and in combination with antifungal drugsPsd1 Effects on Candida albicans Planktonic Cells and BiofilmsFrequent detection of 'azole' resistant Candida species among late presenting AIDS patients in northwest EthiopiaCurrent treatment of oral candidiasis: A literature review.Sustained release of a novel anti-quorum-sensing agent against oral fungal biofilmsAn in vitro study of antifungal drug susceptibility of Candida species isolated from human immunodeficiency virus seropositive and human immunodeficiency virus seronegative individuals in Lucknow population Uttar PradeshSpectrum and the In Vitro Antifungal Susceptibility Pattern of Yeast Isolates in Ethiopian HIV Patients with Oropharyngeal Candidiasis.Oral candidiasis among African human immunodeficiency virus-infected individuals: 10 years of systematic review and meta-analysis from sub-Saharan Africa.Candida spp. adherence to oral epithelial cells and levels of IgA in children with orthodontic appliances.Dynamic analysis of oral Candida carriage, distribution, and antifungal susceptibility in HIV-infected patients during the first year of highly active antiretroviral therapy in Guangxi, China.Nystatin and lidocaine pastilles for the local treatment of oral mucositis.Efficacy of nasal irrigation with 200 μg/mL amphotericin B after functional endoscopic sinus surgery: a randomized, placebo-controlled, double-blind study.Impact of Type and Duration of Application of Commercially Available Oral Moisturizers on Their Antifungal Effects.In Vitro Antifungal Susceptibility of Oral Candida Isolates from Patients Suffering from Caries and Chronic Periodontitis.
P2860
Q28478335-677812AD-4504-4E4A-90A9-0BC51D6693EDQ28484112-D8A20160-4064-4055-A2E6-EA017BBA836BQ33780738-70B264B3-D110-4218-8FB1-B7A951272F76Q34582330-45DF4BE9-E48E-469E-AD7A-49E22126CD61Q35034247-1DADD0FC-9128-40E6-872D-855EDEB30DE7Q35168906-30F6AB18-0161-4EFD-AAE7-C130370CC60BQ36180176-6084895E-D177-4968-BFD5-DAA0D92077F6Q36530366-E4B12CF7-439F-4135-8E1F-94F5B1943B86Q40106799-4C710810-1647-4301-B227-B73FA8377B83Q46869619-ED2B26B2-D411-4837-B0AC-405703F47B48Q46879388-9479B5F9-572A-4105-8005-9FD0C5EB23AAQ47400944-936869CF-E59B-4A02-BACA-6F1A8D3FBCA2Q47725041-9E48B90A-E7D1-4798-9D89-D7ADCFF1A0C6Q47883950-D69617CB-20F7-4791-86EE-0CCF3636CB45Q48310145-C40DAD40-78F4-4A79-AC13-35B7D174D8AA
P2860
In vitro antifungal susceptibility of Candida spp. oral isolates from HIV-positive patients and control individuals.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
In vitro antifungal susceptibi ...... ients and control individuals.
@en
In vitro antifungal susceptibi ...... ients and control individuals.
@nl
type
label
In vitro antifungal susceptibi ...... ients and control individuals.
@en
In vitro antifungal susceptibi ...... ients and control individuals.
@nl
prefLabel
In vitro antifungal susceptibi ...... ients and control individuals.
@en
In vitro antifungal susceptibi ...... ients and control individuals.
@nl
P2093
P1476
In vitro antifungal susceptibi ...... ients and control individuals.
@en
P2093
Aline Cássia Inocêncio
Antonio Olavo Cardoso Jorge
Graziella Nuernberg Back Brito
Sílvia Maria Rodrigues Querido
P356
10.1590/S1806-83242011005000001
P577
2011-01-21T00:00:00Z